HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Benjamin Bonavida Selected Research

Phosphatidylethanolamine Binding Protein

1/2019Identifying Crosstalk between Raf Kinase Inhibitor Protein and Systemic Lupus Erythematosus.
8/2018RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact.
4/2017Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
1/2017Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: Contrasting roles in the regulation of chemo/immuno-resistance in cancer.
1/2014Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer.
1/2012Inhibition of Epithelial-to-Mesenchymal Transition (EMT) in Cancer by Nitric Oxide: Pivotal Roles of Nitrosylation of NF-κB, YY1 and Snail.
6/2011Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival.
1/2009The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs.
10/2007Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Benjamin Bonavida Research Topics

Disease

103Neoplasms (Cancer)
06/2022 - 01/2002
22Neoplasm Metastasis (Metastasis)
03/2018 - 10/2007
19Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2014 - 03/2002
15Prostatic Neoplasms (Prostate Cancer)
10/2017 - 10/2002
15Multiple Myeloma
09/2014 - 01/2003
9Carcinogenesis
12/2021 - 01/2002
7Hematologic Neoplasms (Hematological Malignancy)
08/2018 - 01/2003
7Carcinoma (Carcinomatosis)
01/2015 - 06/2004
6Lymphoma (Lymphomas)
09/2020 - 12/2002
5B-Cell Lymphoma (Lymphoma, B Cell)
11/2015 - 02/2007
5Acquired Immunodeficiency Syndrome (AIDS)
10/2008 - 03/2002
4Melanoma (Melanoma, Malignant)
01/2021 - 02/2011
4Urinary Bladder Neoplasms (Bladder Cancer)
04/2012 - 03/2002
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020 - 10/2015
2Breast Neoplasms (Breast Cancer)
01/2014 - 01/2009
2Inflammation (Inflammations)
07/2012 - 01/2009
2Colonic Neoplasms (Colon Cancer)
05/2009 - 03/2003
2Brain Neoplasms (Brain Tumor)
02/2009 - 04/2008
2Glioma (Gliomas)
02/2009 - 04/2008
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2020
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2020
1Autoimmune Diseases (Autoimmune Disease)
01/2019
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2019
1Immune System Diseases (Immune Disorders)
01/2019
1Burkitt Lymphoma (Burkitt's Lymphoma)
02/2016

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
02/2022 - 03/2002
27Pharmaceutical PreparationsIBA
04/2017 - 10/2002
23NF-kappa B (NF-kB)IBA
12/2021 - 06/2004
22Transcription Factors (Transcription Factor)IBA
02/2022 - 01/2003
21Rituximab (Mabthera)FDA Link
01/2020 - 03/2002
19Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2021 - 06/2004
13Monoclonal AntibodiesIBA
01/2020 - 11/2003
11LigandsIBA
01/2020 - 10/2002
9Biomarkers (Surrogate Marker)IBA
08/2021 - 07/2007
9Phosphatidylethanolamine Binding ProteinIBA
01/2019 - 10/2007
8Proto-Oncogene Proteins c-rafIBA
01/2018 - 10/2007
72,2'- (hydroxynitrosohydrazono)bis- ethanamineIBA
02/2013 - 10/2005
7DNA (Deoxyribonucleic Acid)IBA
02/2009 - 03/2003
6Nitric Oxide DonorsIBA
01/2020 - 06/2004
6Indicators and Reagents (Reagents)IBA
08/2014 - 03/2002
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2011 - 10/2002
5CytokinesIBA
12/2021 - 01/2003
5AntibodiesIBA
01/2019 - 01/2004
5Messenger RNA (mRNA)IBA
01/2017 - 07/2007
5Bortezomib (Velcade)FDA Link
02/2010 - 04/2006
5Proteasome InhibitorsIBA
02/2010 - 04/2006
41-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2015 - 04/2013
4CaspasesIBA
04/2012 - 10/2002
4Cisplatin (Platino)FDA LinkGeneric
03/2012 - 03/2002
3Death Domain ReceptorsIBA
10/2021 - 03/2002
3TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
10/2017 - 10/2007
3Cytotoxins (Cytolysins)IBA
12/2015 - 11/2008
3pheophorbide aIBA
02/2015 - 04/2013
3RNA (Ribonucleic Acid)IBA
03/2014 - 07/2007
3Doxorubicin (Adriamycin)FDA LinkGeneric
08/2013 - 08/2010
3Cadherins (E-Cadherin)IBA
01/2011 - 01/2009
3pleiotrophin (HARP)IBA
02/2009 - 06/2006
3Fas Ligand Protein (Fas Ligand)IBA
09/2006 - 10/2002
3Paclitaxel (Taxol)FDA LinkGeneric
01/2004 - 12/2002
3Cytochromes c (Cytochrome c)IBA
12/2002 - 04/2002
3Dactinomycin (Actinomycin)FDA LinkGeneric
12/2002 - 04/2002
2raf KinasesIBA
02/2022 - 12/2021
2Complement System Proteins (Complement)IBA
01/2021 - 12/2006
2ChemokinesIBA
01/2019 - 07/2012
2VaccinesIBA
03/2018 - 06/2006
2p38 Mitogen-Activated Protein KinasesIBA
10/2015 - 12/2006
2Interleukin-6 (Interleukin 6)IBA
01/2014 - 01/2003
2galiximabIBA
08/2013 - 03/2012
2Peptides (Polypeptides)IBA
06/2012 - 02/2011
2ImmunosorbentsIBA
04/2012 - 10/2004
2EnzymesIBA
04/2012 - 10/2004
2IronIBA
11/2011 - 05/2010
2Transferrin Receptors (Transferrin Receptor)IBA
07/2011 - 10/2006
2Melphalan (Alkeran)FDA LinkGeneric
03/2011 - 06/2006
2marizomibIBA
11/2009 - 05/2008
2Transforming Growth Factor beta1 (TGF beta 1)IBA
02/2009 - 07/2007
2Arsenic Trioxide (Trisenox)FDA Link
07/2008 - 08/2007
2Drug CombinationsIBA
04/2008 - 02/2003
2Peptide Hydrolases (Proteases)FDA Link
11/2003 - 04/2002
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
06/2022
1Glycogen Synthase Kinase 3 betaIBA
12/2021
1SurvivinIBA
09/2020
1Programmed Cell Death 1 ReceptorIBA
09/2019
1AutoantibodiesIBA
01/2019
1Immune Checkpoint InhibitorsIBA
01/2019
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2018
1MicroRNAs (MicroRNA)IBA
02/2016
1human MIRN363 microRNAIBA
02/2016
1Therapeutic UsesIBA
12/2015
1CalciumIBA
03/2015
1sacituzumab govitecanIBA
03/2015
1Phosphotransferases (Kinase)IBA
01/2014
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2014
12- methoxyoestra- 1,3,5(10),16- tetraene- 3- carboxamideIBA
01/2014

Therapy/Procedure

36Therapeutics
10/2021 - 01/2002
21Immunotherapy
01/2021 - 01/2002
21Drug Therapy (Chemotherapy)
01/2020 - 01/2002
4Photochemotherapy (Photodynamic Therapy)
12/2015 - 04/2013
2Radiotherapy
09/2019 - 06/2015
1Adjuvant Chemotherapy
01/2021